BeOne Medicines

Call Directions Website

BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide.

BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.

We all share the responsibility to report adverse events observed with our products so that they may be investigated, actioned, and communicated accordingly.

To report an adverse event or side effect, please talk to your healthcare provider and contact us here: https://beonemedicines.com/contact-us/report-adverse-events/

10/29/2026

One Save Changes Everything.

As comes to a close, one takeaway stands out: innovation is moving quickly.

Progress rarely comes from one idea alone. It comes from sustained innovation, collaboration and a shared determination across the oncology community to meet patient needs.

Thank you to everyone who connected with us throughout .

Adiós, Madrid. As   comes to a close, we’re reflecting on a week that brought together innovative thinking, new mileston...
10/27/2026

Adiós, Madrid.

As comes to a close, we’re reflecting on a week that brought together innovative thinking, new milestones, and a global community united by one of the most complex challenges in medicine – stopping cancer.

Thank you to everyone who visited our booth, joined our sessions and connected with our team.

Discover how we’re changing the game in solid tumor oncology: https://bit.ly/4yY3Vln

10/26/2026

We’re catching up with in the moment. Hear their takes on the science catching attention at and what it could mean for the field – and for patients.

Discover how we’re changing the game in solid tumor oncology: https://bit.ly/4yY3Vln

10/21/2026

For many cancers, the past decade has brought remarkable progress. For people living with hepatocellular carcinoma (HCC), the most common type of liver cancer, progress has been more complicated, and the need for new options remains.

HCC is a complex disease, often developing alongside underlying liver damage, which can make treatment particularly challenging.

At BeOne, we believe changing the outlook starts with understanding what makes HCC different and pursuing science designed around the disease – with the needs of patients at the center.

As new evidence emerges at , we explore why HCC is different from other cancers, and what it could take to move progress forward for patients.

Read the full story: https://bit.ly/4saz3v6

Every person living with chronic lymphocytic leukemia (CLL) is unique and their care should reflect that.   At this year...
10/19/2026

Every person living with chronic lymphocytic leukemia (CLL) is unique and their care should reflect that.

At this year’s international CLL Horizons conference, we hosted a symposium bringing together patient advocates from around the world to explore how shared decision-making can help put patient priorities at the heart of CLL care.

Building on insights from our recently launched White Paper, the discussion highlighted the importance of physicians listening to patients and empowering them to play an active role in their treatment decisions.

Thank you to Dr. Talha Munir, Montse Moharra, Pierre Aumont and CLL Advocates Network for contributing to these meaningful conversations.

Learn more in our White Paper:https://beonemedicines.com/CLL_White_Paper.pdf

10/16/2026

AI is reshaping the future of cancer care. Patients and advocates must have a seat at the table from the start.

We recently welcomed more than 50 patients, advocates and leaders from across healthcare and technology to our Hopewell campus for BeOne’s Patient Advocacy Leadership Summit on AI in Cancer Care.

Together, we tackled some of the biggest questions surrounding AI in cancer care: How do we build trust? Protect access? Preserve human judgment? And how do ensure that patients and patient advocacy groups have a voice in how these technologies are developed and used?

One message came through clearly: Realizing AI's full potential will take collaboration, accountability and a shared commitment to keeping patients at the center.

This was just the beginning. The future of AI in cancer care is still being written, and we all have a role in shaping what comes next. Let’s build it together!

If you joined us at the summit, share the organization or patient community you represented in the comments.

10/14/2026

🌅 CLL Horizons 2026 is here!

This Friday, the global CLL community gathers in Barcelona for three days of learning, connection and collaboration under this year’s theme: Strength in Science, Power in Community.

🔬We are excited to hear from clinicians, researchers and patient advocates as they share the latest breakthroughs in CLL, explore new questions in care and research, and discuss what these advances mean for people living with CLL.

But Horizons is about more than sessions.

It is about the conversations in between: reconnecting with old friends, welcoming new faces, exchanging experiences and uniting diverse perspectives.🧡

🤝Together, we’ll shape the future of CLL advocacy and care.

See you in Barcelona!

📍 16–18 October 2026

10/02/2026

We're just over a month out from our 14th Powwow for Hope, relatives! We're excitedly finalizing details and looking forward to gathering with everyone.

This event wouldn't be possible without our amazing sponsors, like our friends at BeOne Medicines who stepped up as our presenting sponsor this year.

BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide, and we are so grateful for their partnership and dedication to supporting the work we do in Indian Country. ❤️🙌

09/29/2026

“We are getting a better understanding of the tumor…and there's something very unique about HER2.”

Dr. Jaffer Ajani shares his insights on how advances in cancer therapies have transformed the treatment landscape for patients, and why continued innovation in is so important.

Check out the latest installment of Expert Answers in HER2+ Gastroesophageal Cancer to learn more.

Learn more: https://bit.ly/4e5Krma

09/23/2026

Scientific progress has transformed what’s possible for people living with chronic lymphocytic leukemia (CLL). But the healthcare system has failed to keep pace with science.

Too many patients still face gaps in biomarker testing, CLL expertise, care coordination, insurance coverage and more that stand between them and the latest advances in CLL care.

That’s why we partnered with Charles River Associates and the broader blood cancer community on a first-of-its-kind national assessment of the CLL care ecosystem: When Innovation Outpaces Access: Closing the Gap in CLL Care.

The report outlines five actions to help more patients receive the right treatment at the right time:

✅ Expand access to biomarker testing
✅ Improve access to scientifically accurate information
✅ Connect more patients to CLL expertise
✅ Reduce insurance barriers that delay or deny treatment
✅ Increase transparency and promote responsible AI in cancer care

Learn more and download the full report: https://bit.ly/4ALYA1V

Address

55 Cambridge Parkway, Suite 700W
Cambridge, MA
02142

Alerts

Be the first to know and let us send you an email when BeOne Medicines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Nearby clinics